Urteste S.A. (WSE:URT)
Poland · Delayed Price · Currency is PLN 52.60
+0.80 (1.54%)
Aug 14, 2025, 2:31 PM CET
Urteste Revenue
Urteste had revenue of 720.00K PLN in the quarter ending March 31, 2025, a decrease of -26.75%. This brings the company's revenue in the last twelve months to 1.54M, down -33.49% year-over-year. In the year 2024, Urteste had annual revenue of 1.80M with 35.34% growth.
Revenue (ttm)
1.54M
Revenue Growth
-33.49%
P/S Ratio
47.51
Revenue / Employee
46.58K
Employees
20
Market Cap
73.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.80M | 470.00K | 35.34% |
| Dec 31, 2023 | 1.33M | 1.33M | 44,233.33% |
| Dec 31, 2022 | 3.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.06B |
| NEUCA | 12.82B |
| Voxel | 556.98M |
| Synektik Spólka Akcyjna | 623.20M |
| Celon Pharma | 215.11M |
| Ryvu Therapeutics | 97.57M |
| Selvita | 359.79M |
| Centrum Medyczne ENEL-MED | 762.83M |